Orexo Usincis A Key Part Of Orexo Aba Swedish Pharmaceutical Company Founded In 1995 And Based In Uppsalaswedenthe Company Focuses On Developing Proprietary Drug Delivery Technologies To Create Improved Pharmaceuticalsparticularly For Substance Abuse Treatmentwith Around 130 Employees In Sweden And The Usorexo Aligns Its Operations With The Unae S Sustainable Development Goal 3 5Emphasizing Substance Abuse Prevention And Treatment Orexo Specializes In Drug Development Using Its Amorphoxaplatformwhich Enhances The Bioavailability And Stability Of Various Drug Formulationsthe Company Markets Products Directly In The Usincluding Zubsolva Treatment For Opioid Dependenceand Abstrala Rapid Acting Fentanyl Formulation For Breakthrough Cancer Painadditionallyorexo Offers Digital Mental Health Programs Like Modia And Deprexis To Support Patient Care For Those Dealing With Opioid Use Disorder And Other Mental Health Conditionsthe Company Is Committed To Sustainability And Collaborates With Global Partners For Drug Development And Commercialization
No conferences found for this company.
| Company Name | Orexo Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
